Literature DB >> 10660606

Requirement for prolonged action in the cytosol for optimal protein synthesis inhibition by diphtheria toxin.

P O Falnes1, S Ariansen, K Sandvig, S Olsnes.   

Abstract

Diphtheria toxin A-fragment enters the cytosol of target cells, where it inhibits protein synthesis by catalyzing ADP-ribosylation of elongation factor 2 (EF-2). We have here analyzed toxin-induced protein synthesis inhibition in single cells by autoradiography and compared it with inhibition of protein synthesis in the whole cell culture. The data show that half-maximal protein synthesis inhibition in the whole cell population after a short incubation time is achieved by partially inhibiting protein synthesis in basically all the cells, while half-maximal protein synthesis inhibition after a long incubation time is due to a complete protein synthesis block in about half the cells in the population. We have also compared stable and unstable A-fragment mutants with respect to the kinetics of cell intoxication. While the toxicity of the stable mutants increased with time, the unstable mutants showed a similar toxicity at early and late time points. When studying the kinetics of cell intoxication by toxins with short cytosolic half-life, we could not detect any recovery of protein synthesis at late time points when all the mutant A-fragments should be degraded. This indicates that the ADP-ribosylation of EF-2 cannot be reversed by an endogenous activity in the cells. The data indicate that entry of toxin into a cell is not associated with an immediate block in protein synthesis, and that prolonged action of single A-fragment molecules in the cytosol is sufficient to obtain complete protein synthesis inhibition at low toxin concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660606     DOI: 10.1074/jbc.275.6.4363

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release.

Authors:  A Galmiche; J Rassow; A Doye; S Cagnol; J C Chambard; S Contamin; V de Thillot; I Just; V Ricci; E Solcia; E Van Obberghen; P Boquet
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

2.  ADP-ribosylation of translation elongation factor 2 by diphtheria toxin in yeast inhibits translation and cell separation.

Authors:  Maria K Mateyak; Terri Goss Kinzy
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

3.  Reductive methylation and mutation of an anthrax toxin fusion protein modulates its stability and cytotoxicity.

Authors:  Christopher Bachran; Pradeep K Gupta; Silke Bachran; Clinton E Leysath; Benjamin Hoover; Rasem J Fattah; Stephen H Leppla
Journal:  Sci Rep       Date:  2014-04-23       Impact factor: 4.996

Review 4.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

Review 5.  Bacteria in cancer therapy: a novel experimental strategy.

Authors:  S Patyar; R Joshi; D S Prasad Byrav; A Prakash; B Medhi; B K Das
Journal:  J Biomed Sci       Date:  2010-03-23       Impact factor: 8.410

Review 6.  Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities.

Authors:  Mansour Sedighi; Abed Zahedi Bialvaei; Michael R Hamblin; Elnaz Ohadi; Arezoo Asadi; Masoumeh Halajzadeh; Vahid Lohrasbi; Nima Mohammadzadeh; Taghi Amiriani; Marcela Krutova; Abolfazl Amini; Ebrahim Kouhsari
Journal:  Cancer Med       Date:  2019-04-05       Impact factor: 4.452

7.  Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions.

Authors:  Christopher Bachran; Thomas Morley; Suzanne Abdelazim; Rasem J Fattah; Shihui Liu; Stephen H Leppla
Journal:  mBio       Date:  2013-04-30       Impact factor: 7.786

8.  The apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65.

Authors:  Daniela S Silva; Liliana M G Pereira; Ana R Moreira; Frederico Ferreira-da-Silva; Rui M Brito; Tiago Q Faria; Irene Zornetta; Cesare Montecucco; Pedro Oliveira; Jorge E Azevedo; Pedro J B Pereira; Sandra Macedo-Ribeiro; Ana do Vale; Nuno M S dos Santos
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.